Device / Technology News

RSS

Concentric Medical commences TREVO Study of Stentriever technology in ischemic stroke patients

Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced the start of the TREVO Study. The first patients were enrolled and successfully treated at the Hospital Clinic de Barcelona by the Neuroradiology team of Drs. Juan Macho and Jordi Blasco.

30 Sep 2010

New caproKits enable investigation of small molecule–protein interactions

caprotec bioanalytics GmbH announced today the commercial launch of three new caproKits, enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development.

30 Sep 2010

New report addresses difficult issues for design of health insurance exchanges

A new report from The Commonwealth Fund provides recommendations for state and federal policymakers as they design and implement the new health insurance exchanges which are a key element of the Patient Protection and Affordable Care Act (ACA).

30 Sep 2010

Tryton reports positive interim results from Side Branch Stent System study

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced interim six-month results from a symposium during the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference in Washington, D.C.

30 Sep 2010

Iowa Medicaid Enterprise selects Ingenix to manage Program Integrity initiative

The Iowa Medicaid Enterprise (IME), a unique combination of State employees and commercial vendors responsible for managing Iowa's $3 billion Medicaid program, has chosen Ingenix to manage its Program Integrity initiative to help ensure that taxpayer dollars are properly spent.

30 Sep 2010

New online CDSMP program launched to battle against chronic illnesses

Taking the battle against the national epidemic of chronic illnesses to the Internet, the National Council on Aging (NCOA) is making Better Choices, Better Health, the online version of the internationally recognized Chronic Disease Self Management Program (CDSMP), available free for people in California and six other states Hawaii, Iowa, Maine, Massachusetts, New Jersey, and Oregon.

30 Sep 2010

AccuPSA test for detecting prostate cancer recurrence

A new test could reliably detect early increases in prostate specific antigen (PSA) levels a biomarker commonly used to measure the recurrence of prostate cancer in men who have undergone prostate cancer treating surgery. Earlier detection of these rising levels would allow men with cancer recurrence to undergo earlier, more effective treatment for potentially better outcomes.

30 Sep 2010

Scientists use NMR technology to improve protein purification in drug development

The purification of drug components is a large hurdle facing modern drug development. This is particularly true of drugs that utilize proteins, which are notoriously difficult to separate from other potentially deadly impurities. Scientists within the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute are using nuclear magnetic resonance (NMR) to understand and improve an important protein purification process.

30 Sep 2010

Mammography examinations reduce breast cancer mortality rate: SCRY Study

Mammography examinations of women aged 40-49 reduce breast cancer mortality by 29%, a statistically significant reduction. This is shown in the Umeå-directed national SCRY Study in Sweden, which is the largest study of its kind ever performed anywhere in the world.

30 Sep 2010

BSD receives patent for heat therapy applicators

BSD Medical Corporation announced today that a patent has been issued to the Company for a new class of heat therapy applicators (antennas). The United States (US) patent office issued the new patent, Transparent electromagnetic applicator and hyperthermia treatment method, to BSD for a unique design for antennas that provides significant benefits for heat therapy applications.

30 Sep 2010

Access Pharmaceuticals reports significant progress in Cobalamin-targeted drug-delivery program for siRNA therapies

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced today that it has made significant progress with its proprietary Cobalamin-targeted drug-delivery program for siRNA therapies.

30 Sep 2010

Radiologists urge judicious use of radiation-based imaging in children

A CT scan can mean the difference between an accurate and a wrong diagnosis, timely and delayed treatment and, in some cases, life and death. But because CT scans and other tests that use X-ray technology expose the body to often large doses of radiation, their unnecessary, repeated and excessive use may increase cancer risk, especially in children.

30 Sep 2010

Researchers develop C5 technology to identify CTCs in breast cancer

Researchers have identified a novel, dual-platform technology, the On-Q-ity Circulating Cancer Capture and Characterization Chip (C5), which they believe is more efficient than the commonly used single-platform device in identifying circulating tumor cells (CTCs) in breast cancer.

30 Sep 2010

Kaiser Permanente donates Convergent Medical Terminology for open access

Kaiser Permanente is donating its Convergent Medical Terminology (CMT) for open access to help facilitate the nation's transition from paper-based medical records to Electronic Health Records (EHR). CMT was designed by clinicians to facilitate the use of EHRs by clinicians and patients. Kaiser Permanente has the world's largest private sector electronic health record.

29 Sep 2010

NIAID study utilizes Biojector B2000 system to explore syringe, needle benefits

Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, today announced that its unique Needle-Free Injection Therapy (NFIT) system, the Biojector 2000, is being utilized in a study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) which is part of the U.S. National Institutes of Health (NIH).

29 Sep 2010

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc., today announced the latest results from the IN.PACT drug-eluting balloon (DEB) clinical program presented last week at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference.

29 Sep 2010

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

GeneGo, Inc., the leading systems biology tools company and Omicsoft Corporation, the leader in the OMIC repository and analysis field, announced today integration of Omicsoft's Next Generation Sequencing tools with GeneGo's MetaCore data mining suite.

29 Sep 2010

AccessClosure enters agreement with Benrikal Services for Bengal Radial Compression Band distribution

AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Benrikal Services to distribute the Bengal Radial Compression Band in the United States.

29 Sep 2010

TeleHealth Services extends partnership with SVHC to enhance patient education initiatives

TeleHealth Services, the nation's leading provider of healthcare-grade televisions and interactive patient education solutions, today announced an extension of a seven year partnership with St. Vincent's HealthCare (SVHC) to further enhance the hospital's patient education initiatives. The health system will utilize TeleHealth's technology in St. Vincent's Medical Center and new addition, St. Luke's Hospital.

29 Sep 2010

Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery

Ligon Discovery, the innovator of Small Molecule Microarray technology, today announced that it has partnered with Bayer Schering Pharma AG, Germany, to apply its proprietary Small Molecule Microarray screening platform (SMM) to discover potential first-in-class drug candidates for new disease targets.

29 Sep 2010

Device / Technology News

Concentric Medical commences TREVO Study of Stentriever technology in ischemic stroke patients

New caproKits enable investigation of small molecule–protein interactions

New report addresses difficult issues for design of health insurance exchanges

Tryton reports positive interim results from Side Branch Stent System study

Iowa Medicaid Enterprise selects Ingenix to manage Program Integrity initiative

New online CDSMP program launched to battle against chronic illnesses

AccuPSA test for detecting prostate cancer recurrence

Scientists use NMR technology to improve protein purification in drug development

Mammography examinations reduce breast cancer mortality rate: SCRY Study

BSD receives patent for heat therapy applicators

Access Pharmaceuticals reports significant progress in Cobalamin-targeted drug-delivery program for siRNA therapies

Radiologists urge judicious use of radiation-based imaging in children

Researchers develop C5 technology to identify CTCs in breast cancer

Kaiser Permanente donates Convergent Medical Terminology for open access

NIAID study utilizes Biojector B2000 system to explore syringe, needle benefits

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

AccessClosure enters agreement with Benrikal Services for Bengal Radial Compression Band distribution

TeleHealth Services extends partnership with SVHC to enhance patient education initiatives

Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Latest News